You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Teva reveals critical Ajovy data

Teva Pharmaceutical Industries has announced positive data from its pan-European PEARL research, focusing on the impact of Ajovy – also known as fremanezumab.